Related Experiment Videos

Foreword to: buprenorphine and buprenorphine/naloxone: a guide for clinicians

Paul J Fudala, T Peter Bridge

Drug and Alcohol Dependence

|May 10, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder.

Drug and alcohol dependence reports·2023

Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS.

Drug and alcohol dependence·2021

Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.

Journal of clinical psychopharmacology·2020

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2019

Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study.

Journal of clinical psychopharmacology·2016

Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder.

Journal of clinical psychopharmacology·2015

See all related articles